We cannot rule out the possibility that individuals heterozygous for an MBD4 LOF variant have a small increased risk of CRC and/or polyposis,21 but at present, no colonoscopy surveillance beyond population screening or local guidelines based on familial history for CRC is recommended. This evidence concerns the gene MBD4 and polyposis.